Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription Articles published in JAMA Retrieve available abstracts of 215 articles: HTML format

Single Articles

September 2025
1. RUDMAN SPERGEL AK, Callendret B, Kostanyan L
   Influenza and COVID-19 Multicomponent Vaccine in Adults-Reply.
   JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12225.
   PubMed    
   
   
   
2. LIU Z, Zhang L, Jiang M
   Influenza and COVID-19 Multicomponent Vaccine in Adults.
   JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12222.
   PubMed    
   
   
   July 2025
3. UYEKI TM
   Pediatric Influenza-Associated Acute Necrotizing Encephalopathy-Gaps Need to Be Addressed.
   JAMA. 2025 Jul 30. doi: 10.1001/jama.2025.13003.
   PubMed    
   
   
   
4. SILVERMAN A, Walsh R, Santoro JD, Thomas K, et al
   Influenza-Associated Acute Necrotizing Encephalopathy in US Children.
   JAMA. 2025 Jul 30:e2511534. doi: 10.1001/jama.2025.11534.
   PubMed     Abstract available
   
   
   May 2025
5. RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al
   Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults >/=50 Years: A Randomized Clinical Trial.
   JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646.
   PubMed     Abstract available
   
   
   April 2025
6. MOIN EE, Seewald NJ, Halpern SD
   Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.
   JAMA. 2025 Apr 14:e252163. doi: 10.1001/jama.2025.2163.
   PubMed     Abstract available
   
   
   February 2025
7. WU PH, Ho YY, Chang CM
   Electronic Nudges for Influenza Vaccination.
   JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26532.
   PubMed    
   
   
   
8. JOHANSEN ND, Biering-Sorensen T
   Electronic Nudges for Influenza Vaccination-Reply.
   JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26535.
   PubMed    
   
   
   January 2025
9. BOCK A
   CDC Advises Expedited Influenza Subtyping in Hospitalized Patients to Help Identify Bird Flu Cases Sooner.
   JAMA. 2025 Jan 31. doi: 10.1001/jama.2025.0679.
   PubMed    
   
   
   December 2024
10. ANDERER S
    CDC Calls Attention to Underuse of Antiviral Treatment in Higher-Risk Youth With Influenza.
    JAMA. 2024 Dec 27. doi: 10.1001/jama.2024.25515.
    PubMed    
    
    
    
11. GENG LN, Erlandson KM, Hornig M, Letts R, et al
    2024 Update of the RECOVER-Adult Long COVID Research Index.
    JAMA. 2024 Dec 18. doi: 10.1001/jama.2024.24184.
    PubMed     Abstract available
    
    
    
12. MAIA IS, Kawano-Dourado L, Tramujas L, de Oliveira NE, et al
    High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial.
    JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26244.
    PubMed     Abstract available
    
    
    October 2024
13. TADROUS M, Callaway Kim K, Hernandez I, Rothenberger SD, et al
    Differences in Drug Shortages in the US and Canada.
    JAMA. 2024 Oct 31. doi: 10.1001/jama.2024.17688.
    PubMed     Abstract available
    
    
    
14. 
    Audio Highlights: September 14-20, 2024.
    JAMA. 2024;332:e2318402.
    PubMed    
    
    
    
15. HABIB AR, Ijaz N
    Public Health Crisis in Gaza-Reply.
    JAMA. 2024;332:1305-1306.
    PubMed    
    
    
    
16. JOHANSEN ND, Vaduganathan M, Bhatt AS, Modin D, et al
    Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical Trial.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.21060.
    PubMed     Abstract available
    
    
    September 2024
17. AMBA V, Cooper MSL, Sommers BD
    History Repeats-The Election Battle for Medicaid in 2024.
    JAMA. 2024;332:867-868.
    PubMed    
    
    
    
18. RUBIN R
    The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.16432.
    PubMed    
    
    
    
19. GOODMAN JL, Bright RA, Lurie N
    H5 Influenza Vaccines-Moving Forward Against Pandemic Threats.
    JAMA. 2024 Sep 4. doi: 10.1001/jama.2024.17488.
    PubMed    
    
    
    
20. SURIE D, Self WH, Zhu Y, Yuengling KA, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older.
    JAMA. 2024 Sep 4:e2415775. doi: 10.1001/jama.2024.15775.
    PubMed    
    
    
    
21. 
    Audio Highlights.
    JAMA. 2024;332:e2318388.
    PubMed    
    
    
    August 2024
22. WOOLF SH
    Increasing Mortality Rates in the US, but Not From COVID-19.
    JAMA. 2024 Aug 29. doi: 10.1001/jama.2024.13626.
    PubMed    
    
    
    
23. AHMAD FB, Cisewski JA, Anderson RN
    Leading Causes of Death in the US, 2019-2023.
    JAMA. 2024 Aug 8. doi: 10.1001/jama.2024.15563.
    PubMed    
    
    
    
24. HARRIS E
    Does Infectious Bird Flu Virus Persist After Pasteurization?
    JAMA. 2024;332:362.
    PubMed    
    
    
    
25. HARRIS E
    NIH Starts Testing Nasal COVID-19 Vaccine in US.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13769.
    PubMed    
    
    
    July 2024
26. HARRIS E
    CDC Revises RSV Vaccination Recommendation for Older Adults in US.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13385.
    PubMed    
    
    
    
27. HARRIS E
    COVID-19 Vaccination in Early Pregnancy Not Linked to Birth Defects.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13389.
    PubMed    
    
    
    
28. YOUMSHAJEKIAN L
    COVID-19 May Protect Against the Common Cold-Here's Why Knowing That Could Lead to Better Vaccines.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13382.
    PubMed    
    
    
    
29. ABBASI J
    As a Third Worker Tests Positive for Bird Flu in US Dairy Cattle Outbreak, Here's What to Know.
    JAMA. 2024;332:267-269.
    PubMed    
    
    
    
30. AGARWAL SD, Cook BL, Liebman JB
    Effect of Cash Benefits on Health Care Utilization and Health: A Randomized Study.
    JAMA. 2024 Jul 22:e2413004. doi: 10.1001/jama.2024.13004.
    PubMed     Abstract available
    
    
    
31. FRIEDL N, Sporreiter M, Winkler C, Heublein A, et al
    Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection.
    JAMA. 2024 Jul 15:e2411174. doi: 10.1001/jama.2024.11174.
    PubMed    
    
    
    
32. HARRIS E
    Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231.
    PubMed    
    
    
    
33. RUBIN R
    Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992.
    PubMed    
    
    
    
34. HARRIS E
    Review Calls for Standardized Long COVID Definition.
    JAMA. 2024;332:97.
    PubMed    
    
    
    
35. FANG Z, Ahrnsbrak R, Rekito A
    Evidence Mounts That About 7% of US Adults Have Had Long COVID.
    JAMA. 2024;332:5-6.
    PubMed    
    
    
    June 2024
36. SCRUGGS-WODKOWSKI EA, Malani PN, Linder KA
    Therapies to Decrease Severe Respiratory Syncytial Virus Illness.
    JAMA. 2024;331:2127-2128.
    PubMed    
    
    
    
37. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    PubMed    
    
    
    
38. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    PubMed     Abstract available
    
    
    
39. VAN DER LINDEN S, Roozenbeek J
    "Inoculation" to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    PubMed    
    
    
    
40. ABBASI J
    Bird Flu Outbreak in Dairy Cows Is Widespread, Raising Public Health Concerns.
    JAMA. 2024;331:1789-1791.
    PubMed    
    
    
    
41. ANGUS DC, Huang AJ, Lewis RJ, Abernethy AP, et al
    The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.4088.
    PubMed     Abstract available
    
    
    May 2024
42. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    PubMed    
    
    
    
43. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed    
    
    
    
44. KOJIMA N, Blumberg A, Radcliffe R, Flannery B, et al
    US Public Health Preparedness and Response to Highly Pathogenic Avian Influenza A(H5N1) Viruses.
    JAMA. 2024 May 21:e2410116. doi: 10.1001/jama.2024.10116.
    PubMed    
    
    
    
45. BOCK A
    Researchers See Hope in Symptom-Guided Exercise for Long COVID With Postexertional Malaise.
    JAMA. 2024;331:1609-1611.
    PubMed    
    
    
    
46. HARRIS E
    CDC: H5N1 Bird Flu Confirmed in Person Exposed to Cattle.
    JAMA. 2024;331:1615.
    PubMed    
    
    
    
47. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed    
    
    
    
48. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    PubMed    
    
    
    
49. 
    Audio Highlights.
    JAMA. 2024;331:e2318283.
    PubMed    
    
    
    
50. WEN X, Yan J, Zhu Z
    Apixaban to Prevent Recurrence After Cryptogenic Stroke.
    JAMA. 2024 May 13. doi: 10.1001/jama.2024.6848.
    PubMed    
    
    
    
51. HARRIS E
    National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
    PubMed    
    
    
    
52. HARRIS E
    Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
    JAMA. 2024;331:1439-1440.
    PubMed    
    
    
    
53. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed    
    
    
    
54. CHESHIRE WP, Dudenkov DV, Munipalli B
    Tilt Table Testing.
    JAMA. 2024;331:1494-1495.
    PubMed    
    
    
    April 2024
55. HARRIS E
    WHO Launches Broad Coronavirus Surveillance Network.
    JAMA. 2024 Apr 26. doi: 10.1001/jama.2024.6724.
    PubMed    
    
    
    
56. ALLEN MR, Desai N, Namazi A, Leas E, et al
    Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
    JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
    PubMed    
    
    
    
57. HARRIS E
    Meta-Analysis: "Limited" Benefits to Rapid Viral Tests in EDs.
    JAMA. 2024;331:1355.
    PubMed    
    
    
    
58. HARRIS E
    Deaths From Excessive Drinking Rose in the US During Pandemic.
    JAMA. 2024;331:1355.
    PubMed    
    
    
    
59. HARRIS E
    Antidepressant Prescriptions for Female Teens Surged After Pandemic.
    JAMA. 2024;331:1266.
    PubMed    
    
    
    
60. ANDERER S
    Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    PubMed    
    
    
    
61. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    PubMed    
    
    
    
62. HARRIS E
    Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
    PubMed    
    
    
    
63. DAWOOD FS, Payne AB, McMorrow ML
    Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
    JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
    PubMed    
    
    
    
64. ANDERER S
    Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
    JAMA. 2024;331:1082.
    PubMed    
    
    
    March 2024
65. HARRIS E
    COVID-19 Infection Tied to Slight Cognitive Deficits.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
    PubMed    
    
    
    
66. HARRIS E
    COVID-19 Associated With Higher Risk of Autoimmune Diseases.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2092.
    PubMed    
    
    
    
67. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
    Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
    JAMA. 2024;331:938-950.
    PubMed     Abstract available
    
    
    
68. HARRIS E
    CDC Tracking BA.2.87.1, New Omicron Subvariant With Potential to Evade Immunity.
    JAMA. 2024;331:907.
    PubMed    
    
    
    
69. NIELSEN FM, Klitgaard TL, Siegemund M, Laake JH, et al
    Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial.
    JAMA. 2024 Mar 19:e242934. doi: 10.1001/jama.2024.2934.
    PubMed     Abstract available
    
    
    
70. SCHWARTZSTEIN RM
    Oxygen Supplementation in COVID-19-How Much Is Enough?
    JAMA. 2024 Mar 19. doi: 10.1001/jama.2024.2935.
    PubMed    
    
    
    
71. ANDERER S
    CDC Recommends Additional COVID-19 Booster for Older Adults.
    JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
    PubMed    
    
    
    
72. MCKENZIE C, Moore L, Borthwick M
    Vitamin C for Patients Hospitalized With COVID-19.
    JAMA. 2024;331:886.
    PubMed    
    
    
    
73. ADHIKARI NKJ, Lamontagne F
    Vitamin C for Patients Hospitalized With COVID-19-Reply.
    JAMA. 2024;331:886-887.
    PubMed    
    
    
    
74. HARRIS E
    Virtual Group Exercise Program Improved Long COVID Symptoms.
    JAMA. 2024;331:822.
    PubMed    
    
    
    
75. HARRIS E
    Better Outcomes When Kidney Damage Is From COVID-19.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1574.
    PubMed    
    
    
    
76. HARRIS E
    HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
    PubMed    
    
    
    
77. HARRIS E
    Millions of US Children Experience Range of Long COVID Effects.
    JAMA. 2024;331:726.
    PubMed    
    
    
    February 2024
78. ANDERSSON NW, Thiesson EM, Hviid A
    Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
    PubMed    
    
    
    
79. HARRIS E
    New Antiviral on the Horizon for Mild to Moderate COVID-19.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729.
    PubMed    
    
    
    
80. GRAETZ N, Hepburn P, Gershenson C, Porter SR, et al
    Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction.
    JAMA. 2024;331:592-600.
    PubMed     Abstract available
    
    
    
81. RUBIN R
    When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike.
    JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
    PubMed    
    
    
    
82. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
    Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
    JAMA. 2024;331:396-407.
    PubMed     Abstract available
    
    
    
83. FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
    JAMA. 2024;331:408-416.
    PubMed     Abstract available
    
    
    January 2024
84. HARRIS E
    Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340.
    PubMed    
    
    
    
85. RUBIN R
    Paxlovid Is Effective but Underused-Here's What the Latest Research Says About Rebound and More.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28254.
    PubMed    
    
    
    
86. RUBIN R
    As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".
    JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841.
    PubMed    
    
    
    
87. RUBIN R
    From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent Respiratory Disease Surges.
    JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608.
    PubMed    
    
    
    
88. HARRIS E
    High-Dose Flu Vaccine May Be More Effective for Midlife Adults.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26114.
    PubMed    
    
    
    
89. HARRIS E
    Long COVID in Nursing Home Residents Manifests as Functional Decline.
    JAMA. 2024;331:15.
    PubMed    
    
    
    December 2023
90. HARRIS E
    Disproportionate Death Rates Reported in US Prisons Early in the COVID-19 Pandemic.
    JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25770.
    PubMed    
    
    
    
91. HARRIS E
    Using Throat Swabs Improved Sensitivity in Detecting SARS-CoV-2.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25267.
    PubMed    
    
    
    
92. HARRIS E
    Program Offering Free COVID-19 and Flu Services Expands Nationwide.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25268.
    PubMed    
    
    
    
93. HARRIS E
    Life Expectancy in US Climbed After Declines Related to COVID-19.
    JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24683.
    PubMed    
    
    
    
94. SURAN M
    Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID.
    JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24103.
    PubMed    
    
    
    
95. RUBIN R
    Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.0644.
    PubMed    
    
    
    
96. MATHEW P, Feldmann M
    Treatment of Adults Hospitalized With COVID-19 Pneumonia.
    JAMA. 2023;330:2122-2123.
    PubMed    
    
    
    
97. POWDERLY WG, LaVange L, Bozzette SA
    Treatment of Adults Hospitalized With COVID-19 Pneumonia-Reply.
    JAMA. 2023;330:2123.
    PubMed    
    
    
    November 2023
98. EASTMAN Q
    Study Shows Businesses Selling Unapproved Stem Cell Treatments Have Turned to Long COVID.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23897.
    PubMed    
    
    
    
99. BERGMAN C
    Treatment of SARS-CoV-2 Infection in US Nursing Homes.
    JAMA. 2023;330:2021-2022.
    PubMed    
    
    
    
100. MCGARRY BE, Sommers BD, Barnett ML
     Treatment of SARS-CoV-2 Infection in US Nursing Homes-Reply.
     JAMA. 2023;330:2022.
     PubMed    
     
     
     
101. HARRIS E
     COVID Moonshot Drove Discovery of Potential COVID-19 Antivirals.
     JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22934.
     PubMed    
     
     
     
102. HARRIS E
     Smell, Taste Issues After Mild COVID-19 Resolve Over 3 Years.
     JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22930.
     PubMed    
     
     
     
103. HARRIS E
     Long COVID Linked With Viral Persistence, Serotonin Decline.
     JAMA. 2023;330:1827.
     PubMed    
     
     
     
104. HARRIS E
     Audit Finds US National Stockpile "Was Not Equipped" for the Pandemic.
     JAMA. 2023;330:1828.
     PubMed    
     
     
     
105. STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al
     Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
     JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363.
     PubMed     Abstract available
     
     
     
106. HARRIS E
     Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials.
     JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22353.
     PubMed    
     
     
     
107. HARRIS E
     FDA Will Evaluate First Self-Administered FluMist Vaccine.
     JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21870.
     PubMed    
     
     
     
108. HARRIS E
     Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS.
     JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21872.
     PubMed    
     
     
     
109. HARRIS E
     HRSA Study: US Abortions Decreased 14% During COVID-19.
     JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21178.
     PubMed    
     
     
     October 2023
110. ADHIKARI NKJ, Hashmi M, Tirupakuzhi Vijayaraghavan BK, Haniffa R, et al
     Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
     JAMA. 2023 Oct 25:e2321407. doi: 10.1001/jama.2023.21407.
     PubMed     Abstract available
     
     
     
111. JABALEY CS, Coopersmith CM
     Vitamin C for Patients With COVID-19: More Evidence of Lack of Efficacy in Patients With Sepsis.
     JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.18592.
     PubMed    
     
     
     
112. HARRIS E
     US Survey: About 7% of Adults, 1% of Children Have Had Long COVID.
     JAMA. 2023;330:1516.
     PubMed    
     
     
     
113. KOJIMA N, Peterson L, Hawkins R, Allen M, et al
     Influenza Antiviral Shortages Reported by State and Territorial Public Health Officials, 2022-2023.
     JAMA. 2023 Oct 20. doi: 10.1001/jama.2023.17244.
     PubMed    
     
     
     
114. HARRIS E
     COVID-19 Hospitalizations Up Among Older Adults.
     JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19796.
     PubMed    
     
     
     
115. HARRIS E
     Previous COVID-19 Linked With Autoimmune Conditions.
     JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19798.
     PubMed    
     
     
     
116. BATRA A, Nath A, Koralnik IJ
     Postacute Sequelae of SARS-CoV-2 Infection.
     JAMA. 2023;330:1491-1492.
     PubMed    
     
     
     
117. THAWEETHAI T, Foulkes AS
     Postacute Sequelae of SARS-CoV-2 Infection-Reply.
     JAMA. 2023;330:1492.
     PubMed    
     
     
     
118. HARRIS E
     Exercise Programs Might Improve Long COVID.
     JAMA. 2023;330:1421.
     PubMed    
     
     
     
119. HARRIS E
     Wastewater Surveillance Predicts Large-Scale Flu, RSV Trends.
     JAMA. 2023;330:1422.
     PubMed    
     
     
     
120. HARRIS E
     Changes in SARS-CoV-2 Sequence Linked With Antiviral Use.
     JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19202.
     PubMed    
     
     
     September 2023
121. HARRIS E
     NIH Launches Phase 1 Trial of Broader "Universal" Flu Vaccine.
     JAMA. 2023 Sep 27. doi: 10.1001/jama.2023.18741.
     PubMed    
     
     
     
122. HARRIS E
     Some People Still Have Long COVID Symptoms After 2 Years.
     JAMA. 2023;330:1127.
     PubMed    
     
     
     
123. RUBIN R
     Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months.
     JAMA. 2023 Sep 18. doi: 10.1001/jama.2023.19759.
     PubMed    
     
     
     
124. TARTOF SY, Frankland TB, Slezak JM, Puzniak L, et al
     Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years.
     JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17473.
     PubMed    
     
     
     
125. HARRIS E
     Two New Analyses Add to Long COVID Understanding.
     JAMA. 2023;330:905-906.
     PubMed    
     
     
     
126. LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al
     SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
     JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348.
     PubMed     Abstract available
     
     
     
127. HARRIS E
     High Blood Pressure More Likely After COVID-19 Than Flu.
     JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676.
     PubMed    
     
     
     
128. HARRIS E
     HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
     JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678.
     PubMed    
     
     
     
129. HARRIS E
     CDC Recommends RSV Immunization for Infants.
     JAMA. 2023;330:797.
     PubMed    
     
     
     
130. HARRIS E
     Federal Government Announces Long COVID Trials, Research Office.
     JAMA. 2023;330:797.
     PubMed    
     
     
     
131. KENTISH-BARNES N, Resche-Rigon M, Lafarge A, Souppart V, et al
     PTSD Symptoms Among Family Members of Patients With ARDS Caused by COVID-19 After 12 Months.
     JAMA. 2023 Sep 1. doi: 10.1001/jama.2023.15879.
     PubMed    
     
     
     August 2023
132. HARRIS E
     Severe COVID-19 Linked to Enduring Immune System Changes.
     JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16109.
     PubMed    
     
     
     
133. HARRIS E
     CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant.
     JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16105.
     PubMed    
     
     
     
134. HARRIS E
     FDA Approves Maternal RSV Vaccine.
     JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16106.
     PubMed    
     
     
     
135. HARRIS E
     Human Infections With Swine Influenza Viruses Identified in US.
     JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15451.
     PubMed    
     
     
     
136. HARRIS E
     Lung Transplants for COVID-19 Similarly Successful.
     JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15450.
     PubMed    
     
     
     
137. ABBASI J
     What to Know About EG.5, the Latest SARS-CoV-2 "Variant of Interest".
     JAMA. 2023 Aug 18. doi: 10.1001/jama.2023.16498.
     PubMed    
     
     
     
138. RUBIN R
     Why Blood Type Seems to Be Linked With COVID-19 Risk.
     JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.15996.
     PubMed    
     
     
     
139. RAGLOW Z, Malani PN, Petty LA
     Outpatient Treatment for COVID-19.
     JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.16666.
     PubMed    
     
     
     
140. DOS SANTOS RAS, Taccone FS, Annoni F
     Renin-Angiotensin System Modulation in Adults With COVID-19.
     JAMA. 2023;330:663-664.
     PubMed    
     
     
     
141. SELF WH, DeClercq J, Orr M
     Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
     JAMA. 2023;330:664-665.
     PubMed    
     
     
     
142. HARRIS E
     FDA Approves RSV Monoclonal Antibody for Infants and Young Children.
     JAMA. 2023;330:586.
     PubMed    
     
     
     
143. ABBASI J
     Vigilance Urged Against Bird Flu Amid Ongoing Outbreaks in Mammals.
     JAMA. 2023;330:583-584.
     PubMed    
     
     
     
144. ABBASI J
     A Genetic Explanation for Why Some People Had Asymptomatic COVID-19.
     JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.14703.
     PubMed    
     
     
     
145. DAVIDSON BL, Levi MM
     Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
     JAMA. 2023;330:471-472.
     PubMed    
     
     
     
146. GOLIGHER EC, Lawler PR, Zarychanski R
     Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply.
     JAMA. 2023;330:472-473.
     PubMed    
     
     
     July 2023
147. SURAN M
     HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID's Mental Health Symptoms.
     JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13605.
     PubMed    
     
     
     
148. HARRIS E
     Free COVID-19 Vaccinations on the Way for Uninsured Adults.
     JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.
     PubMed    
     
     
     
149. GLEASON JL, Tamburro R, Signore C
     Promoting Data Harmonization of COVID-19 Research in Pregnant and Pediatric Populations.
     JAMA. 2023 Jul 20. doi: 10.1001/jama.2023.10835.
     PubMed    
     
     
     
150. MCGARRY BE, Sommers BD, Wilcock AD, Grabowski DC, et al
     Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes.
     JAMA. 2023 Jul 14:e2312945. doi: 10.1001/jama.2023.12945.
     PubMed    
     
     
     
151. O'HALLORAN JA, Ko ER, Anstrom KJ, Kedar E, et al
     Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
     JAMA. 2023 Jul 10:e2311043. doi: 10.1001/jama.2023.11043.
     PubMed     Abstract available
     
     
     
152. RUBIN R
     This Fall's COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen.
     JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.10053.
     PubMed    
     
     
     June 2023
153. HARRIS E
     Patients With COVID-19 and Fungal Infections Had High Mortality Rates.
     JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11957.
     PubMed    
     
     
     
154. MICHAELS D, Wagner GR, Ryan L
     Lessons From COVID-19 for Protecting Workers in the Next Pandemic.
     JAMA. 2023 Jun 16. doi: 10.1001/jama.2023.8229.
     PubMed    
     
     
     
155. ANDREWS N, Stowe J, Miller E, Ramsay M, et al
     BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
     JAMA. 2023 Jun 15. doi: 10.1001/jama.2023.10123.
     PubMed    
     
     
     
156. HARRIS E
     Hybrid COVID-19 Immunity Common by Fall of 2022.
     JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10399.
     PubMed    
     
     
     
157. HARRIS E
     Consistent Exercise Tied to Lower Risk of Death From Flu, Pneumonia.
     JAMA. 2023;329:1907-1908.
     PubMed    
     
     
     
158. HARRIS E
     FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment.
     JAMA. 2023 Jun 7. doi: 10.1001/jama.2023.9925.
     PubMed    
     
     
     May 2023
159. THAWEETHAI T, Jolley SE, Karlson EW, Levitan EB, et al
     Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
     JAMA. 2023 May 25:e238823. doi: 10.1001/jama.2023.8823.
     PubMed     Abstract available
     
     
     
160. GROSS R, Lo Re V 3rd
     Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One, Many).
     JAMA. 2023 May 25. doi: 10.1001/jama.2023.8961.
     PubMed    
     
     
     
161. HARRIS E
     CDC Updates COVID-19 Data Reporting as US Public Health Emergency Ends.
     JAMA. 2023 May 24. doi: 10.1001/jama.2023.9150.
     PubMed    
     
     
     
162. WEISS A, Donnachie E, Beyerlein A, Ziegler AG, et al
     Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19.
     JAMA. 2023 May 22:e238674. doi: 10.1001/jama.2023.8674.
     PubMed    
     
     
     
163. HARRIS E
     WHO Declares End of COVID-19 Global Health Emergency.
     JAMA. 2023 May 17. doi: 10.1001/jama.2023.8656.
     PubMed    
     
     
     
164. HARRIS E
     COVID-19 Vaccine and Health Care Visits for Menstrual Changes.
     JAMA. 2023 May 17. doi: 10.1001/jama.2023.8658.
     PubMed    
     
     
     
165. HARRIS E
     FDA Clears RSV Vaccine for Adults Aged 60 Years or Older.
     JAMA. 2023 May 17. doi: 10.1001/jama.2023.8657.
     PubMed    
     
     
     
166. ASHRAF S, Ashraf N
     Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19.
     JAMA. 2023;329:1702.
     PubMed    
     
     
     
167. MCCARTHY MW, Lindsell CJ, Naggie S
     Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply.
     JAMA. 2023;329:1702-1703.
     PubMed    
     
     
     
168. MARCUS R
     New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a Nasal Spray for Migraines-Highlights From the 2023 American Academy of Neurology Conference.
     JAMA. 2023 May 10. doi: 10.1001/jama.2023.4389.
     PubMed    
     
     
     
169. HARRIS E
     RSV Infection Might Be Resuming Prepandemic Patterns.
     JAMA. 2023;329:1544.
     PubMed    
     
     
     
170. HARRIS E
     BCG Vaccine Not Effective Against COVID-19.
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.7763.
     PubMed    
     
     
     
171. HARRIS E
     RSV Infection During Infancy Tied to Asthma Later.
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.7765.
     PubMed    
     
     
     
172. HARRIS E
     XBB.1.16 Deemed COVID-19 "Variant of Interest".
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.7768.
     PubMed    
     
     
     
173. LANDHUIS EW
     How Primary Care Physicians Can Recognize and Treat Long COVID.
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.6604.
     PubMed    
     
     
     
174. BOMMERSBACH TJ, McKean AJ, Olfson M, Rhee TG, et al
     National Trends in Mental Health-Related Emergency Department Visits Among Youth, 2011-2020.
     JAMA. 2023;329:1469-1477.
     PubMed     Abstract available
     
     
     April 2023
175. HARRIS E
     WHO: Confirmed Avian Influenza Death in China.
     JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6622.
     PubMed    
     
     
     
176. HARRIS E
     FDA Simplifies COVID-19 Vaccination, Permits Some Additional Doses.
     JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6624.
     PubMed    
     
     
     
177. HARRIS E
     How Parents' Views Are Tied to Children's COVID-19 Vaccination.
     JAMA. 2023 Apr 19. doi: 10.1001/jama.2023.6292.
     PubMed    
     
     
     
178. HARRIS E
     RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials.
     JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6254.
     PubMed    
     
     
     
179. HARRIS E
     Updated WHO Guidance for Prioritizing COVID-19 Vaccines.
     JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6256.
     PubMed    
     
     
     
180. LEE MMY, McMurray JJV
     Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19.
     JAMA. 2023;329:1155-1156.
     PubMed    
     
     
     
181. SELF WH, Shotwell MS, Gibbs KW, de Wit M, et al
     Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
     JAMA. 2023;329:1170-1182.
     PubMed     Abstract available
     
     
     
182. LAWLER PR, Derde LPG, van de Veerdonk FL, McVerry BJ, et al
     Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
     JAMA. 2023;329:1183-1196.
     PubMed     Abstract available
     
     
     
183. XIE Y, Choi T, Al-Aly Z
     Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022-2023.
     JAMA. 2023 Apr 6. doi: 10.1001/jama.2023.5348.
     PubMed    
     
     
     
184. HARRIS E
     Study: US COVID-19 Outcomes Tied to State Characteristics and Policies.
     JAMA. 2023 Apr 5. doi: 10.1001/jama.2023.5622.
     PubMed    
     
     
     
185. AMMIRATI E, Moslehi JJ
     Diagnosis and Treatment of Acute Myocarditis: A Review.
     JAMA. 2023;329:1098-1113.
     PubMed     Abstract available
     
     
     
186. HARRIS E
     Public Had Most Trust in Advice From Physicians, Nurses During Pandemic.
     JAMA. 2023;329:1053.
     PubMed    
     
     
     
187. HARRIS E
     "Living" Systematic Review of Mental Health During Pandemic.
     JAMA. 2023;329:1054.
     PubMed    
     
     
     
188. HARRIS E
     Human Flu Cases in Cambodia Not Due to Bird Flu Outbreak Viruses.
     JAMA. 2023;329:1053.
     PubMed    
     
     
     
189. ESMAIL LC, Kapp P, Assi R, Wood J, et al
     Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19.
     JAMA. 2023 Apr 3:e234590. doi: 10.1001/jama.2023.4590.
     PubMed    
     
     
     March 2023
190. HARRIS E
     Cold Virus Provided Cross-reactivity Against SARS-CoV-2 in Children.
     JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5261.
     PubMed    
     
     
     
191. CAMPO R
     Illness Metaphors and COVID-19.
     JAMA. 2023;329:1035.
     PubMed    
     
     
     
192. HARRIS E
     Nasally Administered Monoclonal Antibody for COVID-19.
     JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4000.
     PubMed    
     
     
     
193. LONDON AJ, Seymour CW
     The Ethics of Clinical Research: Managing Persistent Uncertainty.
     JAMA. 2023;329:884-885.
     PubMed    
     
     
     
194. GOLIGHER EC, Lawler PR, Jensen TP, Talisa V, et al
     Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
     JAMA. 2023 Mar 21. doi: 10.1001/jama.2023.3651.
     PubMed     Abstract available
     
     
     
195. COKER TR, Cheng TL, Ybarra M
     Addressing the Long-term Effects of the COVID-19 Pandemic on Children and Families: A Report From the National Academies of Sciences, Engineering, and Medicine.
     JAMA. 2023 Mar 16. doi: 10.1001/jama.2023.4371.
     PubMed    
     
     
     
196. HARRIS E
     FDA Approves First Over-the-counter Combined COVID-19 and Flu Test.
     JAMA. 2023 Mar 8. doi: 10.1001/jama.2023.3192.
     PubMed    
     
     
     
197. SURAN M
     Long COVID Linked With Unemployment in New Analysis.
     JAMA. 2023;329:701-702.
     PubMed    
     
     
     
198. HARRIS E
     Meta-analysis: COVID-19 Infection Protects Against Severe Disease.
     JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2885.
     PubMed    
     
     
     
199. HARRIS E
     Prior COVID-19 Infection Tied to Lasting Lung Abnormalities.
     JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2886.
     PubMed    
     
     
     
200. RUBIN R
     Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
     JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.0158.
     PubMed    
     
     
     February 2023
201. NEPRASH HT, Golberstein E, Ganguli I, Chernew ME, et al
     Association of Evaluation and Management Payment Policy Changes With Medicare Payment to Physicians by Specialty.
     JAMA. 2023;329:662-669.
     PubMed     Abstract available
     
     
     
202. ABBASI J
     Bird Flu Has Begun to Spread in Mammals-Here's What's Important to Know.
     JAMA. 2023;329:619-621.
     PubMed    
     
     
     
203. HARRIS E
     Study: No New SARS-CoV-2 Variants in Recent Outbreak in China.
     JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2089.
     PubMed    
     
     
     
204. HARRIS E
     COVID-19 Vaccination During Pregnancy Protected Infants.
     JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2098.
     PubMed    
     
     
     
205. LARKIN H
     National Academies: Expand US Wastewater Disease Surveillance.
     JAMA. 2023;329:531.
     PubMed    
     
     
     
206. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
     Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
     JAMA. 2023 Feb 20:e231650. doi: 10.1001/jama.2023.1650.
     PubMed     Abstract available
     
     
     
207. BIBBINS-DOMINGO K, Malani PN
     At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19.
     JAMA. 2023 Feb 20. doi: 10.1001/jama.2023.1922.
     PubMed    
     
     
     
208. HARRIS E
     NIH Considers Lessons Learned During COVID-19 Pandemic.
     JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1553.
     PubMed    
     
     
     
209. HARRIS E
     Most COVID-19 Deaths Worldwide Were Among Older People.
     JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1554.
     PubMed    
     
     
     
210. RUBIN R
     Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA.
     JAMA. 2023 Feb 15. doi: 10.1001/jama.2022.22285.
     PubMed    
     
     
     
211. HARRIS E
     Updated COVID-19 Guidance for People Who Are Immunocompromised.
     JAMA. 2023 Feb 8. doi: 10.1001/jama.2023.1176.
     PubMed    
     
     
     
212. LARKIN H
     Newly Discovered Host-Cell Factor Could Be a COVID-19 Treatment Target.
     JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0748.
     PubMed    
     
     
     
213. LARKIN H
     High COVID-19 Rates Prompt Call for Better Nursing Home Protections.
     JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0740.
     PubMed    
     
     
     
214. LARKIN H
     Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
     JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0743.
     PubMed    
     
     
     October 2021
215. RADWANY S
     Our Best Judgment.
     JAMA. 2021;326:1373-1374.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.